Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of B-MoGen Biotechnologies Inc. B-MoGen Biotechnologies Inc. translates the world’s most powerful genome editing technology into greatly needed products throughout the life sciences and based in Minneapolis.
Fredrikson’s legal team was led by Melodie Rose, Ryan Brauer, and Eldri Johnson.
Read the news release.
